Curebound
Curebound is a San Diego-based public charity that raises and invests funding in adult and pediatric cancer research. Its grantmaking emphasizes collaboration across institutions and advancing research toward clinical application.
Key facts about Curebound
In short: Curebound gave $10.2M across 11 grants in 2025 (avg $931K), mostly in California. 27% of 2025 grantees were new. Source: 2025 IRS Form 990.
- EIN
- 46-0552414
- Latest 990 filing
- Form 990, 2025
- Annual giving (2025)
- $10,238,599
- Grants made (2025)
- 11
- Average grant
- $930,782
- Median grant
- $337,270
- New grantees (estimate)
- 27% first-time grantees (3 of 11, 2025)
- Total assets
- $11,857,815
- Primary geography
- California (99% of itemized 2025 grant dollars)
- How to apply
- The website says proposals undergo peer review. Full details ↓
Data from IRS Form 990, 2025; updated September 2026. New grantees are estimated by matching recipient names across years (methodology). Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Financial Overview
From 2025 IRS Form 990 · View filing
Total Assets
$11.9M
-27.9% YoY
Annual Giving
$10.2M
+44.5% YoY
Grant Count
11
+10.0% YoY
Avg Grant Size
$931K
+31.4% YoY
Is Curebound open to new grantees?
27%
first-time grantees, 2025
In 2025, 3 of 11 grantees (27%) were first-time recipients. First grants averaged $229K; repeat grants $1.2M. How we count
Medians: $250K first-time, $461K repeat.
Estimate from itemized grant lists in IRS Form 990 filings (2019–2025). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Mission & Focus Areas
Curebound states its mission is to accelerate cancer research and save lives. It funds oncology research for adult and pediatric cancers across five stated research pillars: Cancer Detection; Novel Approaches, Targets, and Therapeutics; Personalized Immunotherapy; Cancer Equity; and Childhood Cancers.
The organization’s website says its grants require collaboration among specialized teams led by San Diego-based research institutions. Eligible team-leader institutions include UC San Diego, the Salk Institute, Sanford Burnham Prebys, Rady Children’s Hospital, La Jolla Institute for Immunology, and Scripps Research. The 2025 filing also lists grants to research institutions, universities, and companies.
Among its 2025 grantees, the Salk Institute describes its work as spanning cancer research and other fields, while the La Jolla Institute for Immunology says its scientists study the immune system to promote health and prevent disease, including cancer. These are descriptions of the grantees, not Curebound.
Grantmaking
In filing year 2025, Curebound reported 11 grants totaling **$10,238,599**. Grant amounts ranged from **$6,650 to $5,743,423**, with a median of **$337,270**.
Ready to take the next step with Curebound?
Geographic Focus
Where this funder awards grants
Curebound’s website describes its grant platform as led by San Diego-based research institutions. In filing year 2025, 99% of grant dollars went to recipients in California and 1% to recipients in Arizona.
Grant Distribution by State
Share of 2025 grant dollars across all 11 itemized grants.
States
Cities
Giving Over Time
Total grant dollars and number of grants per year
From 2019 to 2025, annual grant giving ranged from $1.5M (2021) to $10.2M (2025). In 2025 it made 11 grants totaling $10.2M.
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2025
The largest 2025 recipient was The Regents of University of California Uc San Diego ($5.7M). Together the top 10 received $10.2M.
Grant Size Distribution
36 grants across all recorded years
The most common grant size was in the $250–500K range: 13 grants of 36 (36%).
Giving History
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| The Regents of University of California Uc San Diego La Jolla, CA | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $5,743,423 |
| Sanford Burnham Prebys La Jolla, CA | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $1,529,548 |
| The Salk Institute for Biological Studies La Jolla, CA | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $849,414 |
| Scripps Research La Jolla, CA | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $537,267 |
| La Jolla Institute for Immunology La Jolla, CA | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $385,027 |
| San Diego State University Research Foundation San Diego, CA | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $337,270 |
| Beken Bio Inc San Diego, CA | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $250,000 |
| Resolute Science Inc San Diego, CA | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $250,000 |
| Illudent Inc San Diego, CA | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $250,000 |
| University of Arizona Tucson, AZ | See detail in part ivcurebound awards grant funding in early-discovery cancer research and applies scientific and entrepreneurial expertise to help promising research translate into meaningful near-term clinical impact. Funding is directed toward five traditionally under-resourced research pillars: cancer detection, novel approaches, targets, and therapeutics. Personalized immunotherapy, cancer equity, childhood cancers. | $100,000 |
Financial History
Multi-year comparison from IRS filings
| Filing year | Assets | Revenue | Expenses | Grants reported |
|---|---|---|---|---|
| 2025 | $11,857,815 | $10,968,237 | $14,851,654 | $10,238,599 (11 grants) |
| 2024 | $16,440,883 | $5,488,901 | $10,744,443 | $7,083,484 (10 grants) |
| 2023 | $24,388,123 | $10,395,528 | $12,500,342 | $4,404,869 (5 grants) |
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Assets | $11,857,815 | $16,440,883 | $24,388,123 |
| Revenue | $10,968,237 | $5,488,901 | $10,395,528 |
| Expenses | $14,851,654 | $10,744,443 | $12,500,342 |
| Net Investment Income | $343,112 | $522,299 | $246,733 |
Data update history
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2024 (received by the IRS October 1, 2025)
- Updated Form 990 for fiscal year 2019 (received by the IRS March 17, 2020)
- Updated Form 990 for fiscal year 2021 (received by the IRS September 15, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS August 10, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS September 4, 2024)
- Added Form 990 for fiscal year 2025 (received by the IRS July 24, 2026)
- IRS filings on file for fiscal years 2019–2024
Leadership & Key People
Leadership team and compensation from IRS filings
The 2025 filing lists the following directors: Donald B Kearns MD MMM, John Hood PhD, Rob Singh, Haeyoung Tang PhD, Fe Whitworth, Dan Ryan, Court Turner JD, Mark Cafferty, Catriona Jamieson MD PhD, and Rich Heyman PhD.
Curebound is led by Anne Marbarger, Chief Executive Officer since 2024 (on filings since 2019); 7 of 27 officers listed in 2025 are compensated.
Officers on the 2025 filing
Anne Marbarger
Chief Executive Officer
CEO → Chief Executive Officer, 2024
On filings since 2019
40 hrs/week
$159K (2019) → $477K (2025)
Bill Koman
Chairperson
On filings since 2024
1 hr/week
No compensation reported
Heather Ashley Dean-Presnall
Senior Director & Stewardship
Strategic Philanthropy Officer → Senior Director, Stewardship & Revenue Strategy, 2024
Senior Director, Stewardship & Revenue Strategy → Senior Director & Stewardship, 2025
On filings since 2023
40 hrs/week
$121K (2023) → $149K (2025)
Amy Myers
Senior Director & Philanthropy
New on the 2025 filing
40 hrs/week
$147K (2025)
Erik Hans Gordon
Director & Marketing
New on the 2025 filing
40 hrs/week
$134K (2025)
Judith Polha
Director, Research & Impact
New on the 2025 filing
40 hrs/week
$137K (2025)
Chris Tresse
Director
Padres Pedal Advisory Board Chair → Secretary, 2023
Secretary → Director, 2024
On filings since 2020
1 hr/week
No compensation reported
Aaron Davis
Director
On filings since 2021
1 hr/week
No compensation reported
John Hood PhD
Director
Director → Scientific Advisory Board Chair, 2022
Scientific Advisory Board Chair → Director, 2023
On filings since 2021
1 hr/week
No compensation reported
Larry Bloch
Director
On filings since 2021
1 hr/week
No compensation reported
Mark Cafferty
Director
On filings since 2021
1 hr/week
No compensation reported
Rich Heyman PhD
Director
On filings since 2021
1 hr/week
No compensation reported
Court Turner JD
Director
On filings since 2022
1 hr/week
No compensation reported
Magda Marquet PhD
Director
On filings since 2022
1 hr/week
No compensation reported
Rob Singh
Director
On filings since 2022
1 hr/week
No compensation reported
Catriona Jamieson MD PhD
Director
On filings since 2024
1 hr/week
No compensation reported
Dan Ryan
Director
On filings since 2024
1 hr/week
No compensation reported
Fe Whitworth
Director
On filings since 2024
1 hr/week
No compensation reported
Haeyoung Tang PhD
Director
On filings since 2024
1 hr/week
No compensation reported
Julie Tafel Klaus
Director
On filings since 2024
1 hr/week
No compensation reported
Cheryl Am Anderson Phd Mph Ms
Director
New on the 2025 filing
1 hr/week
No compensation reported
Donald B. Kearns Md Mmm
Director
New on the 2025 filing
1 hr/week
No compensation reported
Karen Hooper
Chief Operating Officer
Chief Strategy & Implementation Officer → Chief Operating Officer, 2024
On filings since 2022
40 hrs/week
$138K (2022) → $306K (2025)
Megan Ambrose
Chief of Staff
On filings since 2024
40 hrs/week
$114K (2024) → $142K (2025)
Don Ankeny
Treasurer
Finance Committee Chair → Treasurer, 2023
On filings since 2022
1 hr/week
No compensation reported
Rick Valencia
Vice Chair
On filings since 2024
1 hr/week
No compensation reported
Robin Toft
Secretary
On filings since 2024
1 hr/week
No compensation reported
Former officers (38)
- Former: Cheryl Am Anderson (2021–2024) — Director
- Former: Donald B. Kearns (2021–2024) — Director
- Former: Danielle Dawson (2024) — Philanthropy Officer
- Former: William Koman (2019–2023) — Chairman
- Former: Cat Jamieson (2021–2023) — Director
- Former: Fernanda Whitworth (2021–2023) — Director
- Former: Malin Burnham (2021–2023) — Director
- Former: Daniel Ryan (2022–2023) — Director
- Former: Megan Lee Waddell (2023) — Director & Padres Pedal the Cause
- Former: Jay Levitt (2021–2022) — Director
- Former: Kellie Sullivan (2022) — Senior Manager & Development
- Former: Brett Chodorow (2019–2021) — Director
- Former: Franci Free (2019–2021) — Director
- Former: James Herbst (2019–2021) — Director
- Former: Jean Wickersham (2019–2021) — Director
- Former: Lauren M Diaz (2019–2021) — COO
- Former: Molly Cartmill (2019–2021) — Secretary
- Former: Shelley Zimmerman (2019–2021) — Director
- Former: Suzanne Hatcher (2019–2021) — Director
- Former: Tom Seidler (2019–2021) — Director
- Former: Tony Steigler (2019–2021) — Director
- Former: Dale McIntosh (2020–2021) — Director
- Former: Robert Murtfeldt (2020–2021) — Director
- Former: Ashley van Zeeland (2021) — Director
- Former: Bill Hearne (2021) — Director
- Former: Ezra Cohen (2021) — Director
- Former: Jeffrey Kelly (2021) — Director
- Former: Jon Edwards (2021) — Director
- Former: Mitch Kronenberg (2021) — Director
- Former: Nancy Hong (2021) — Director
- Former: Paula Aristizibal (2021) — Director
- Former: Reuben Shaw (2021) — Director
- Former: Ryan Thorvaldsen (2021) — Director
- Former: Scott Lippman (2021) — Director
- Former: Ze'ev Ronai (2021) — Director
- Former: Jay Indovino (2019–2020) — Director
- Former: Michael Militello (2019) — Director
- Former: Peter Mossy (2019) — Treasurer
Data from IRS Form 990 filings, 2019–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $477K, to Anne Marbarger (Chief Executive Officer). 7 officers or directors reported compensation on that filing.
Contact
Mailing address: 9605 Scranton Road Suite 120, San Diego, CA 92121
Phone: (619) 314-5878
Website: https://curebound.org
Frequently asked questions about Curebound
How much does Curebound give each year?
Curebound gave $10.2M across 11 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $7.1M across 10 grants.
What is Curebound's typical grant size?
Curebound's median grant in 2025 was $337,270, and its average grant was $930,782, across 11 grants on its 2025 IRS Form 990. Organizations receiving their first grant from Curebound that year got $229K on average.
Where does Curebound give grants?
Curebound gives mostly in California: 99% of the grant dollars itemized on its 2025 IRS Form 990 went to recipients there. The most frequent recipient cities were La Jolla, CA (5 grants) and San Diego, CA (5 grants).
Does Curebound give general operating support?
Not in 2025: none of the 11 grants with a stated purpose on Curebound's 2025 IRS Form 990 were described as general or operating support.
Who are Curebound's largest grantees?
Curebound's largest 2025 grantees include The Regents of University of California Uc San Diego ($5,743,423), Sanford Burnham Prebys ($1,529,548) and The Salk Institute for Biological Studies ($849,414), according to its 2025 IRS Form 990. Together they received 79% of its itemized 2025 grant dollars.
How large is Curebound?
Curebound reported $11.9M in total assets on its 2025 IRS Form 990. Its revenue that year was $11.0M.
What does Curebound fund?
Curebound states its mission is to accelerate cancer research and save lives. See mission & focus areas ↑
How do I apply for a grant from Curebound?
The website says proposals undergo peer review. Eligibility and process details are in the grantmaking section of this profile. See how to apply ↑
What is Curebound's EIN?
Curebound's EIN (Employer Identification Number) is 46-0552414. IRS Form 990 filing data is available on this page for 2019–2025.
Data last updated September 2026. Sourced from IRS Form 990 filings. Research dossier generated September 2026.
Here's the math on researching Curebound by hand.
Explore Open Grants
Browse active grant opportunities in Curebound's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Yale University
New Haven, CT
Yale supports education, research, scholarship, preservation, public service, and community organizations, including through sponsored research and fellowships. Its 2025 grants ranged from $3,000 to $14.3 million, with a median of about $136,000; recipients were based mainly in Connecticut, California, Massachusetts, New York, and Pennsylvania. The profile does not state whether Yale accepts unsolicited requests.
Assets
$58.9B
Grants
364
Total Given
$168.2M
The Simons Foundation Inc
New York, NY
The Simons Foundation funds research in mathematics and the basic sciences, as well as autism and other disease research, through grants to research centers, universities, and related organizations. In 2024, grants ranged from $1,480 to $20 million, with a median of $72,000; funding is concentrated in New York, California, and Massachusetts, with awards also made elsewhere in the U.S. and internationally. Whether it accepts unsolicited requests is not stated.
Assets
$4.5B
Grants
1,727
Total Given
$272.0M
Wm Keck Foundation
Los Angeles, CA
The W.M. Keck Foundation funds high-risk, high-potential science, engineering and medical research nationally, plus arts and culture, education, health and community-service projects in Southern California, with an emphasis on children, youth, families and under-resourced communities. Typical awards are $1 million–$1.3 million over three years for research and $100,000–$1 million through its Southern California Program. The profile does not state whether it accepts unsolicited requests.
Assets
$1.7B
Grants
260
Total Given
$69.7M
Emory University
Atlanta, GA
Emory University funds research, health care, and medical research, including university research awards and subcontract grants to organizations. Its 2024 grants had a median of about $87,500, though awards ranged from about $5,300 to $35.5 million; recipients were concentrated in Georgia, which received 46% of grant dollars. The profile does not state whether Emory accepts unsolicited requests.
Assets
$24.9B
Grants
362
Total Given
$183.7M
The Scripps Research Institute
La Jolla, CA
The Scripps Research Institute funds scientific research, especially biomedical and translational research; its 2025 grants had a median of about $146,500, with awards ranging from $5,640 to $9.2 million. It is based in La Jolla, California, and funded organizations in multiple states, with California receiving the largest share of grant dollars; the profile does not state whether it accepts unsolicited requests.
Assets
$1.5B
Grants
141
Total Given
$78.6M
The Ovarian Cancer Research Fund Inc
New York, NY
OCRA funds research on ovarian and related gynecologic cancers, including early detection, prevention, treatment, immunotherapy, and health equity, through grants to eligible nonprofit research institutions worldwide. Its 2024 awards ranged from $75,000 to $900,000, with a median of about $325,000. Researchers may submit a letter of intent through its annual grant cycle; full proposals are by invitation.
Assets
$38.1M
Grants
14
Total Given
$5.7M
Society for Immunotherapy of Cancer Inc
Milwaukee, WI
To improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation, diversity and inclusion and leadership in the field. Sitc aims to make cancer immunotherapy a standard of care and the word "cure" a reality for cancer patients everywhere.
Assets
$21.9M
Grants
9
Total Given
$738K
John & Beverly Stauffer Foundation
Pasadena, CA
The John & Beverly Stauffer Foundation supports a range of charitable organizations, including those in animal care, higher education, historic preservation, performing arts, and community services. In 2025, grants ranged from $1,000 to $25,000, with a median of $5,000; nearly all funding went to California organizations, with a small share in Arizona. It funds only preselected organizations and does not accept unsolicited requests.
Assets
$4.4M
Grants
29
Total Given
$211K
Cele H & William B Rubin Family Fund
Wellesley Hills, MA
The CELE H & William B. Rubin Family Fund supports a range of charitable organizations, with most 2024 grant dollars going to Massachusetts recipients and much of the remainder to Illinois. It awarded 65 grants totaling about $6.0 million in 2024; grants ranged from $250 to $1.17 million, with a median of $6,480. It funds only preselected organizations and does not accept unsolicited requests.
Assets
$34.6M
Grants
65
Total Given
$6.0M
Enberg Family Charitable Foundation
San Diego, CA
Assets
$711K
Grants
3
Total Given
$17K
Alzheimer's Disease & Related Disorders Association Inc
Chicago, IL
The fund supports Alzheimer’s disease and dementia research, including scientific, clinical, social, and behavioral research, as well as related policy work. It awards grants to U.S. and international researchers; the profile does not state a typical giving level or whether unsolicited requests are accepted.
Assets
$523.7M
Grants
79
Total Given
$73.3M
Silicon Valley Community Foundation
Mountain View, CA
Silicon Valley Community Foundation funds work in areas such as housing, economic security, education, health, the environment, arts and culture, and civic engagement, with Community Action Grants supporting local, community-led organizations in San Mateo and Santa Clara counties. Its 2024 grants had a median of $51,716, though amounts varied widely; applications depend on the program, and SVCF states that it does not accept unsolicited proposals for advised funds.
Assets
$12.3B
Grants
3,576
Total Given
$3.2B
More Funders in California
Curebound down — hundreds of funders to go?